Rallybio Corporation (RLYB) analyst actions
Rating and price-target actions on RLYB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the RLYB overview →
3 measured RLYB analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study | Press release | +0.00% | -4.43% | |
| Rallybio Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial | Press release | -1.47% | -4.36% | |
| Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212 | Press release | +0.00% | -1.14% |
Keep exploring
More RLYB: earnings → · SEC filings → · RLYB overview →